Main Expertise
Cell therapies and technologies
Cancer immunotherapy
Translational research in stem cells and regenerative medicine

Operating the Family Cord Blood Bank and Bio Regenerate Inc, a start up company developing adult stem cells technologies and storage services.

Leading research and development programs for medical applications of adult stem cells from various sources such as peripheral blood, bone marrow and cord blood. Program goals are to treat degenerative diseases such as cardiovascular ischemia, diabetic leg and retinal diseases.

Co-investigator in the adoptive immunotherapy program of melanoma, – a cell based therapy program in its clinical phase. Operating a GTP laboratory for cell therapies. Development and production of cell based products in good tissue culture practice (GTP) facility.

Expert in translational research, regulation and developing cell based technologies, products and their clinical applications. Adviser and scientific board member for biotech companies. Co-author of more than 95 scientific publications and 10 patents.

Previously, the founder and CEO of Gamida Cell Ltd.; CEO of Hadasit Ltd., the tech transfer company of the Hadassah Medical Center; Head of the R&D Division of the Hadassah Medical Center and adviser for biotech companies.
PhD from the Weizmann Institute of Science, Israel; Post doc at Stanford University Medical School, CA USA.